Unknown

Dataset Information

0

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?


ABSTRACT: The CC chemokine ligand 18 (CCL18) is produced by alveolar macrophages in patients with fibrosing lung disease and its concentration is increased in various fibrotic lung diseases. Furthermore CCL18 is elevated in several malignancies as it is produced by tumor associated macrophages. In this study we aimed to analyze the role of CCL18 as a prognostic biomarker for the development of early radiation induced lung toxicity (RILT), i.e. radiation pneumonitis after thoracic irradiation and its significance in the course of the disease. Sixty seven patients were enrolled prospectively in the study. Patients were treated with irradiation for several thoracic malignancies (lung cancer, esophageal cancer, thymoma), either with conventionally fractionated or hypo-fractionated radiotherapy. The CCL18 serum levels were quantified with ELISA (enzyme-linked immunosorbent assay) at predefined time points: before, during and at the end of treatment as well as in the first and second follow-up. Treatment parameters and functional tests were also correlated with the development of RILT.Fifty three patients were evaluable for this study. Twenty one patients (39%) developed radiologic signs of RILT Grade >1 but only three of them (5.6%) developed clinical symptoms (Grade 2). We could not find any association between the different CCL18 concentrations and a higher incidence of RILT. Statistical significant factors were the planning target volume (odds ratio OR: 1.003, p = 0.010), the volume of the lung receiving > 20 Gy (OR: 1.132 p = 0.004) and age (OR: 0.917, p = 0.008). There was no association between serial CCL18 concentrations with tumor response and overall survival.In our study the dosimetric parameters remained the most potent predictors of RILT. Further studies are needed in order to estimate the role of CCL18 in the development of early RILT.

SUBMITTER: Gkika E 

PROVIDER: S-EPMC5619767 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Gkika Eleni E   Vach Werner W   Adebahr Sonja S   Schimek-Jasch Tanja T   Brenner Anton A   Brunner Thomas Baptist TB   Kaier Klaus K   Prasse Antje A   Müller-Quernheim Joachim J   Grosu Anca-Ligia AL   Zissel Gernot G   Nestle Ursula U  

PloS one 20170928 9


The CC chemokine ligand 18 (CCL18) is produced by alveolar macrophages in patients with fibrosing lung disease and its concentration is increased in various fibrotic lung diseases. Furthermore CCL18 is elevated in several malignancies as it is produced by tumor associated macrophages. In this study we aimed to analyze the role of CCL18 as a prognostic biomarker for the development of early radiation induced lung toxicity (RILT), i.e. radiation pneumonitis after thoracic irradiation and its signi  ...[more]

Similar Datasets

| S-EPMC4885000 | biostudies-literature
| S-EPMC4552107 | biostudies-literature
| S-EPMC4150478 | biostudies-literature
| S-EPMC3404958 | biostudies-literature
| S-EPMC1965555 | biostudies-literature
2015-09-03 | E-MTAB-1944 | biostudies-arrayexpress
| S-EPMC3548837 | biostudies-literature
| S-EPMC7126766 | biostudies-literature
| S-EPMC9338204 | biostudies-literature
| S-EPMC7958898 | biostudies-literature